The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway

Abstract Rolipram specifically inhibits phosphodiesterase (PDE) 4, thereby preventing inactivation of the intracellular second messenger cyclic adenosine monophosphate (cAMP). Rolipram has been shown to play a neuroprotective role in some central nervous system (CNS) diseases. However, the role of P...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiao-Liu Dong, Yan-Hui Wang, Jing Xu, Nan Zhang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/470d281fdff74772bbad6c240451252d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:470d281fdff74772bbad6c240451252d
record_format dspace
spelling oai:doaj.org-article:470d281fdff74772bbad6c240451252d2021-12-02T18:01:40ZThe protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway10.1038/s41598-021-98743-w2045-2322https://doaj.org/article/470d281fdff74772bbad6c240451252d2021-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-98743-whttps://doaj.org/toc/2045-2322Abstract Rolipram specifically inhibits phosphodiesterase (PDE) 4, thereby preventing inactivation of the intracellular second messenger cyclic adenosine monophosphate (cAMP). Rolipram has been shown to play a neuroprotective role in some central nervous system (CNS) diseases. However, the role of PDE4 and the potential protective effect of rolipram on the pathophysiological process of intracerebral haemorrhage (ICH) are still not entirely clear. In this study, a mouse model of ICH was established by the collagenase method. Rolipram reduced brain oedema, blood–brain barrier (BBB) leakage, neuronal apoptosis and inflammatory cytokine release and improved neurological function in our mouse model of ICH. Moreover, rolipram increased the levels of cAMP and silent information regulator 1 (SIRT1) and upregulated the phosphorylation of AMP-activated protein kinase (AMPK). Furthermore, these effects of rolipram could be reversed by the SIRT1 inhibitor sirtinol. In conclusion, rolipram can play a neuroprotective role in the pathological process of ICH by activating the cAMP/AMPK/SIRT1 pathway.Xiao-Liu DongYan-Hui WangJing XuNan ZhangNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Xiao-Liu Dong
Yan-Hui Wang
Jing Xu
Nan Zhang
The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway
description Abstract Rolipram specifically inhibits phosphodiesterase (PDE) 4, thereby preventing inactivation of the intracellular second messenger cyclic adenosine monophosphate (cAMP). Rolipram has been shown to play a neuroprotective role in some central nervous system (CNS) diseases. However, the role of PDE4 and the potential protective effect of rolipram on the pathophysiological process of intracerebral haemorrhage (ICH) are still not entirely clear. In this study, a mouse model of ICH was established by the collagenase method. Rolipram reduced brain oedema, blood–brain barrier (BBB) leakage, neuronal apoptosis and inflammatory cytokine release and improved neurological function in our mouse model of ICH. Moreover, rolipram increased the levels of cAMP and silent information regulator 1 (SIRT1) and upregulated the phosphorylation of AMP-activated protein kinase (AMPK). Furthermore, these effects of rolipram could be reversed by the SIRT1 inhibitor sirtinol. In conclusion, rolipram can play a neuroprotective role in the pathological process of ICH by activating the cAMP/AMPK/SIRT1 pathway.
format article
author Xiao-Liu Dong
Yan-Hui Wang
Jing Xu
Nan Zhang
author_facet Xiao-Liu Dong
Yan-Hui Wang
Jing Xu
Nan Zhang
author_sort Xiao-Liu Dong
title The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway
title_short The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway
title_full The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway
title_fullStr The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway
title_full_unstemmed The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP/AMPK/SIRT1 pathway
title_sort protective effect of the pde-4 inhibitor rolipram on intracerebral haemorrhage is associated with the camp/ampk/sirt1 pathway
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/470d281fdff74772bbad6c240451252d
work_keys_str_mv AT xiaoliudong theprotectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway
AT yanhuiwang theprotectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway
AT jingxu theprotectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway
AT nanzhang theprotectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway
AT xiaoliudong protectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway
AT yanhuiwang protectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway
AT jingxu protectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway
AT nanzhang protectiveeffectofthepde4inhibitorrolipramonintracerebralhaemorrhageisassociatedwiththecampampksirt1pathway
_version_ 1718378985462693888